important hiv news
2008-Feb-29, Friday 09:50 amTwo important genetic discoveries announced today.
1) It's happened before with TRIM5 gene
Monkeys have, more than once, evolved a genetic defense to lentiviruses (which includes HIV). "An intriguing possibility is that the newly formed genes prevented infection by prehistoric viruses related to modern AIDS viruses. If so, this could mean that AIDS-like epidemics are not unique to our time, but in fact may have plagued our primate ancestors long before the modern AIDS epidemic. " Which, if their idea is correct, means that we can definitively beat this epidemic this time, since it's been done multiple times before by nature.
2) It's happening now with TRIM22 gene
Researchers find a gene that can prevent a cell from assembling more copies of HIV. "This means that TRIM22 is an essential part of our body's ability to fight off HIV. The results are very exciting because they show that our bodies have a gene that is capable of stopping the spread of HIV."
Good to hear. :)
1) It's happened before with TRIM5 gene
Monkeys have, more than once, evolved a genetic defense to lentiviruses (which includes HIV). "An intriguing possibility is that the newly formed genes prevented infection by prehistoric viruses related to modern AIDS viruses. If so, this could mean that AIDS-like epidemics are not unique to our time, but in fact may have plagued our primate ancestors long before the modern AIDS epidemic. " Which, if their idea is correct, means that we can definitively beat this epidemic this time, since it's been done multiple times before by nature.
2) It's happening now with TRIM22 gene
Researchers find a gene that can prevent a cell from assembling more copies of HIV. "This means that TRIM22 is an essential part of our body's ability to fight off HIV. The results are very exciting because they show that our bodies have a gene that is capable of stopping the spread of HIV."
Good to hear. :)
no subject
Date: 2008-Feb-29, Friday 08:27 pm (UTC)At work, we greatly underestimated this problem and found ourselves all dressed up and ready to go - we spent >100M to create the best, most cost-effective genomic screening technology in the world, but ended up without enough human subjects to do the studies we wanted to do with it. And the people who did have patients to work with didn't want to share credit with us by using our services. Nearly killed the company.